Tomas Husmark

Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)

Elke Theander, Tomas Husmark, Gerd-Marie Alenius et al. · Annals of the Rheumatic Diseases · 2013 · 172 citations

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin et al. · BMJ · 2020 · 108 citations · Full text

The Swedish Early Psoriatic Arthritis Registry 5-year Followup: Substantial Radiographic Progression Mainly in Men with High Disease Activity and Development of Dactylitis

Mats Geijer, Ulla Lindqvist, Tomas Husmark et al. · The Journal of Rheumatology · 2015 · 80 citations · Full text

The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.

Ulla Lindqvist, Gerd-Marie Alenius, Tomas Husmark et al. · PubMed · 2008 · 79 citations

Rheumatoid Disorder, Rheumatology, Global Disease Activity +15

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin et al. · Annals of the Rheumatic Diseases · 2023 · 44 citations · Full text